APR-246 enhances the anticancer effect of doxorubicin against p53-mutant AsPC-1 pancreatic cancer cells. Baghdad Sci.J [Internet]. 2024 Aug. 1 [cited 2024 Dec. 22];21(8):2551. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/10135